CYP1A2 encodes an enzyme responsible for metabolizing caffeine. While caffeine can temporarily increase energy expenditure and fat oxidation, the effect on long-term weight loss is modest and highly variable between individuals. The provided context does not contain direct evidence linking CYP1A2 to weight loss. Therefore, the usefulness of CYP1A2 genotyping for weight management is unclear. Some studies suggest that 'slow' metabolizers may experience less benefit or more side effects from caffeine, but this does not translate into a reliable weight-loss strategy. Evidence level: unclear/mechanistic. A DNA test for CYP1A2 might offer insights into caffeine tolerance, but it is not a substitute for proven weight-loss interventions like diet and exercise.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d953a6953d1edef0d7b95c48